Richard A. Paulson - May 4, 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
President and CEO, Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Richard Paulson
Stock symbol
KPTI
Transactions as of
May 4, 2022
Transactions value $
-$177,509
Form type
4
Date filed
5/5/2022, 04:08 PM
Previous filing
Mar 2, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale -$3.96K -633 -0.1% $6.26 661K May 4, 2022 Direct F1
transaction KPTI Common Stock Sale -$174K -27.9K -4.21% $6.23 633K May 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.